(GAP) The Gap - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US3647601083
Stock: Apparel, Accessories, Personal-Care, Athleticwear
Total Rating 57
Risk 92
Buy Signal 0.13
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.96% |
| Yield on Cost 5y | 3.59% |
| Yield CAGR 5y | 7.50% |
| Payout Consistency | 95.2% |
| Payout Ratio | 29.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 50.5% |
| Relative Tail Risk | -18.6% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.68 |
| Alpha | 12.29 |
| Character TTM | |
|---|---|
| Beta | 1.477 |
| Beta Downside | 1.004 |
| Drawdowns 3y | |
|---|---|
| Max DD | 46.40% |
| CAGR/Max DD | 0.75 |
Description: GAP The Gap January 07, 2026
The Gap, Inc. (NYSE:GAP) is a U.S.–based apparel retailer that sells clothing, accessories, and personal-care items for men, women, and children under the Old Navy, Gap, Banana Republic, and Athleta brands. It distributes products through company-operated and franchised stores, its e-commerce sites, third-party retailers, and licensing agreements across North America, Asia, Europe, Latin America, the Middle East, and Africa.
Key operating metrics show FY 2023 revenue of roughly $16.2 billion, with comparable-sales growth down about 5 % year-over-year and an operating margin near 4.5 %. Online sales now represent ~30 % of total revenue, and inventory turnover sits at 4.2 ×, reflecting ongoing pressure from inflation-sensitive consumer spending, higher labor costs, and a competitive shift toward omni-channel and fast-fashion models in the broader apparel retail sector.
For a deeper, data-driven valuation framework, you might explore ValueRay’s analyst tools.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 851.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -3.05 > 1.0 |
| NWC/Revenue: 15.45% < 20% (prev 11.85%; Δ 3.60% < -1%) |
| CFO/TA 0.10 > 3% & CFO 1.22b > Net Income 851.0m |
| Net Debt (3.25b) to EBITDA (1.72b): 1.89 < 3 |
| Current Ratio: 1.72 > 1.5 & < 3 |
| Outstanding Shares: last quarter (380.0m) vs 12m ago -0.78% < -2% |
| Gross Margin: 41.01% > 18% (prev 0.41%; Δ 4060 % > 0.5%) |
| Asset Turnover: 126.2% > 50% (prev 128.5%; Δ -2.38% > 0%) |
| Interest Coverage Ratio: 17.96 > 6 (EBITDA TTM 1.72b / Interest Expense TTM 68.0m) |
Altman Z'' 3.28
| A: 0.19 (Total Current Assets 5.64b - Total Current Liabilities 3.28b) / Total Assets 12.37b |
| B: 0.28 (Retained Earnings 3.50b / Total Assets 12.37b) |
| C: 0.10 (EBIT TTM 1.22b / Avg Total Assets 12.11b) |
| D: 0.41 (Book Value of Equity 3.57b / Total Liabilities 8.72b) |
| Altman-Z'' Score: 3.28 = A |
Beneish M -3.12
| DSRI: 1.01 (Receivables 328.0m/325.0m, Revenue 15.28b/15.23b) |
| GMI: 1.01 (GM 41.01% / 41.27%) |
| AQI: 0.87 (AQ_t 0.07 / AQ_t-1 0.08) |
| SGI: 1.00 (Revenue 15.28b / 15.23b) |
| TATA: -0.03 (NI 851.0m - CFO 1.22b) / TA 12.37b) |
| Beneish M-Score: -3.12 (Cap -4..+1) = AA |
What is the price of GAP shares?
As of February 07, 2026, the stock is trading at USD 29.13 with a total of 3,216,217 shares traded.
Over the past week, the price has changed by +4.11%, over one month by +8.35%, over three months by +28.66% and over the past year by +29.86%.
Over the past week, the price has changed by +4.11%, over one month by +8.35%, over three months by +28.66% and over the past year by +29.86%.
Is GAP a buy, sell or hold?
The Gap has received a consensus analysts rating of 3.63.
Therefor, it is recommend to hold GAP.
- StrongBuy: 4
- Buy: 4
- Hold: 11
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the GAP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 30.3 | 4% |
| Analysts Target Price | 30.3 | 4% |
| ValueRay Target Price | 33.1 | 13.7% |
GAP Fundamental Data Overview January 31, 2026
P/E Trailing = 12.4775
P/E Forward = 11.7371
P/S = 0.6743
P/B = 2.7514
P/EG = 1.5982
Revenue TTM = 15.28b USD
EBIT TTM = 1.22b USD
EBITDA TTM = 1.72b USD
Long Term Debt = 1.49b USD (from longTermDebt, last quarter)
Short Term Debt = 629.0m USD (from shortTermDebt, last quarter)
Debt = 5.52b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.25b USD (from netDebt column, last quarter)
Enterprise Value = 13.56b USD (10.30b + Debt 5.52b - CCE 2.26b)
Interest Coverage Ratio = 17.96 (Ebit TTM 1.22b / Interest Expense TTM 68.0m)
EV/FCF = 17.40x (Enterprise Value 13.56b / FCF TTM 779.0m)
FCF Yield = 5.75% (FCF TTM 779.0m / Enterprise Value 13.56b)
FCF Margin = 5.10% (FCF TTM 779.0m / Revenue TTM 15.28b)
Net Margin = 5.57% (Net Income TTM 851.0m / Revenue TTM 15.28b)
Gross Margin = 41.01% ((Revenue TTM 15.28b - Cost of Revenue TTM 9.01b) / Revenue TTM)
Gross Margin QoQ = 42.36% (prev 41.23%)
Tobins Q-Ratio = 1.10 (Enterprise Value 13.56b / Total Assets 12.37b)
Interest Expense / Debt = 0.05% (Interest Expense 3.00m / Debt 5.52b)
Taxrate = 29.97% (101.0m / 337.0m)
NOPAT = 855.1m (EBIT 1.22b * (1 - 29.97%))
Current Ratio = 1.72 (Total Current Assets 5.64b / Total Current Liabilities 3.28b)
Debt / Equity = 1.51 (Debt 5.52b / totalStockholderEquity, last quarter 3.65b)
Debt / EBITDA = 1.89 (Net Debt 3.25b / EBITDA 1.72b)
Debt / FCF = 4.18 (Net Debt 3.25b / FCF TTM 779.0m)
Total Stockholder Equity = 3.42b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.03% (Net Income 851.0m / Total Assets 12.37b)
RoE = 24.91% (Net Income TTM 851.0m / Total Stockholder Equity 3.42b)
RoCE = 24.88% (EBIT 1.22b / Capital Employed (Equity 3.42b + L.T.Debt 1.49b))
RoIC = 17.43% (NOPAT 855.1m / Invested Capital 4.91b)
WACC = 7.41% (E(10.30b)/V(15.82b) * Re(11.36%) + D(5.52b)/V(15.82b) * Rd(0.05%) * (1-Tc(0.30)))
Discount Rate = 11.36% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.66%
[DCF Debug] Terminal Value 75.07% ; FCFF base≈910.6m ; Y1≈661.3m ; Y5≈369.4m
Fair Price DCF = 12.35 (EV 7.85b - Net Debt 3.25b = Equity 4.59b / Shares 371.9m; r=7.41% [WACC]; 5y FCF grow -32.26% → 2.90% )
[DCF Warning] FCF declining rapidly (-32.26%), DCF may be unreliable
EPS Correlation: 66.61 | EPS CAGR: 18.29% | SUE: 0.24 | # QB: 0
Revenue Correlation: -16.48 | Revenue CAGR: -3.61% | SUE: N/A | # QB: 0
EPS next Quarter (2026-04-30): EPS=0.48 | Chg30d=+0.002 | Revisions Net=+0 | Analysts=7
EPS next Year (2027-01-31): EPS=2.34 | Chg30d=+0.024 | Revisions Net=+2 | Growth EPS=+9.0% | Growth Revenue=+2.5%
P/E Forward = 11.7371
P/S = 0.6743
P/B = 2.7514
P/EG = 1.5982
Revenue TTM = 15.28b USD
EBIT TTM = 1.22b USD
EBITDA TTM = 1.72b USD
Long Term Debt = 1.49b USD (from longTermDebt, last quarter)
Short Term Debt = 629.0m USD (from shortTermDebt, last quarter)
Debt = 5.52b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.25b USD (from netDebt column, last quarter)
Enterprise Value = 13.56b USD (10.30b + Debt 5.52b - CCE 2.26b)
Interest Coverage Ratio = 17.96 (Ebit TTM 1.22b / Interest Expense TTM 68.0m)
EV/FCF = 17.40x (Enterprise Value 13.56b / FCF TTM 779.0m)
FCF Yield = 5.75% (FCF TTM 779.0m / Enterprise Value 13.56b)
FCF Margin = 5.10% (FCF TTM 779.0m / Revenue TTM 15.28b)
Net Margin = 5.57% (Net Income TTM 851.0m / Revenue TTM 15.28b)
Gross Margin = 41.01% ((Revenue TTM 15.28b - Cost of Revenue TTM 9.01b) / Revenue TTM)
Gross Margin QoQ = 42.36% (prev 41.23%)
Tobins Q-Ratio = 1.10 (Enterprise Value 13.56b / Total Assets 12.37b)
Interest Expense / Debt = 0.05% (Interest Expense 3.00m / Debt 5.52b)
Taxrate = 29.97% (101.0m / 337.0m)
NOPAT = 855.1m (EBIT 1.22b * (1 - 29.97%))
Current Ratio = 1.72 (Total Current Assets 5.64b / Total Current Liabilities 3.28b)
Debt / Equity = 1.51 (Debt 5.52b / totalStockholderEquity, last quarter 3.65b)
Debt / EBITDA = 1.89 (Net Debt 3.25b / EBITDA 1.72b)
Debt / FCF = 4.18 (Net Debt 3.25b / FCF TTM 779.0m)
Total Stockholder Equity = 3.42b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.03% (Net Income 851.0m / Total Assets 12.37b)
RoE = 24.91% (Net Income TTM 851.0m / Total Stockholder Equity 3.42b)
RoCE = 24.88% (EBIT 1.22b / Capital Employed (Equity 3.42b + L.T.Debt 1.49b))
RoIC = 17.43% (NOPAT 855.1m / Invested Capital 4.91b)
WACC = 7.41% (E(10.30b)/V(15.82b) * Re(11.36%) + D(5.52b)/V(15.82b) * Rd(0.05%) * (1-Tc(0.30)))
Discount Rate = 11.36% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.66%
[DCF Debug] Terminal Value 75.07% ; FCFF base≈910.6m ; Y1≈661.3m ; Y5≈369.4m
Fair Price DCF = 12.35 (EV 7.85b - Net Debt 3.25b = Equity 4.59b / Shares 371.9m; r=7.41% [WACC]; 5y FCF grow -32.26% → 2.90% )
[DCF Warning] FCF declining rapidly (-32.26%), DCF may be unreliable
EPS Correlation: 66.61 | EPS CAGR: 18.29% | SUE: 0.24 | # QB: 0
Revenue Correlation: -16.48 | Revenue CAGR: -3.61% | SUE: N/A | # QB: 0
EPS next Quarter (2026-04-30): EPS=0.48 | Chg30d=+0.002 | Revisions Net=+0 | Analysts=7
EPS next Year (2027-01-31): EPS=2.34 | Chg30d=+0.024 | Revisions Net=+2 | Growth EPS=+9.0% | Growth Revenue=+2.5%